Materion Co. (NYSE:MTRN – Get Free Report) VP Gregory R. Chemnitz sold 2,000 shares of Materion stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $80.45, for a total value of $160,900.00. Following the sale, the vice president now owns 13,376 shares in the company, valued at $1,076,099.20. This trade represents a 13.01 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Materion Trading Down 1.4 %
NYSE:MTRN opened at $78.43 on Wednesday. The company has a quick ratio of 1.26, a current ratio of 3.19 and a debt-to-equity ratio of 0.48. Materion Co. has a 52-week low of $69.10 and a 52-week high of $123.21. The stock’s 50 day moving average price is $82.29 and its 200 day moving average price is $96.99. The company has a market capitalization of $1.63 billion, a PE ratio of 270.43 and a beta of 0.85.
Materion (NYSE:MTRN – Get Free Report) last announced its earnings results on Thursday, May 1st. The basic materials company reported $1.13 EPS for the quarter, beating analysts’ consensus estimates of $1.12 by $0.01. The business had revenue of $420.33 million for the quarter, compared to analysts’ expectations of $396.83 million. Materion had a net margin of 0.35% and a return on equity of 12.42%. The company’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.96 EPS. On average, research analysts anticipate that Materion Co. will post 5.5 EPS for the current year.
Hedge Funds Weigh In On Materion
About Materion
Materion Corporation, together with its subsidiaries, produces advanced engineered materials used in semiconductor, industrial, aerospace and defense, automotive, energy, consumer electronics, and telecom and data center in the United States, Asia, Europe, and internationally. The company operates in four segments: Performance Materials, Electronic Materials, Precision Optics, and Other.
Read More
- Five stocks we like better than Materion
- Breakout Stocks: What They Are and How to Identify Them
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Utilities Stocks Explained – How and Why to Invest in Utilities
- The Top-Ranked Insider Buys From April by Market Cap
- How to Use the MarketBeat Excel Dividend Calculator
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Materion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Materion and related companies with MarketBeat.com's FREE daily email newsletter.